| Oxytocin to Enhance Integrated Treatment for AUD and PTSD (NCT04523922) | Medical University of South Carolina | 2021-03-29 |
| PRP for Treatment of Peyronie's Disease (NCT04512287) | University of Miami | 2021-03-29 |
| Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study (NCT04793568) | Nantes University Hospital | 2021-03-29 |
| To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19 (NCT04709328) | Sinocelltech Ltd. | 2021-03-28 |
| Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial (NCT04847661) | Helwan University | 2021-03-28 |
| Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients (NCT04750122) | Peking University People's Hospital | 2021-03-28 |
| The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19 (NCT04644185) | Sinocelltech Ltd. | 2021-03-27 |
| Smith-Lemli-Opitz Syndrome and Cholic Acid (NCT03720990) | University of Nebraska | 2021-03-27 |
| A Phase 2 Study of Hemay007 in Patients With Rheumatoid Arthritis (NCT05247216) | Tianjin Hemay Pharmaceutical Co., Ltd | 2021-03-26 |
| A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention (NCT04804033) | Pfizer | 2021-03-26 |
| Enoxacin for Amyotrophic Lateral Sclerosis (ALS) (NCT04840823) | McGill University | 2021-03-26 |
| PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment (NCT04634058) | Shanghai Zhongshan Hospital | 2021-03-26 |
| Pre-Exposure Prophylaxis for Transgender Women in the US and South America (NCT04742491) | HIV Prevention Trials Network | 2021-03-26 |
| Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19 (NCT04748783) | University of North Carolina, Chapel Hill | 2021-03-26 |
| Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1 (NCT04954001) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2021-03-26 |
| Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma (NCT04783415) | City of Hope Medical Center | 2021-03-26 |
| Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population (NCT04932291) | Oryzon Genomics S.A. | 2021-03-26 |
| Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder (NCT04850664) | Evon Medics LLC | 2021-03-26 |
| Tolerability and Efficacy of RJX in Patients With COVID-19 (NCT04708340) | Reven Pharmaceuticals, Inc. | 2021-03-25 |
| Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma (NCT04521153) | Shanghai Zhongshan Hospital | 2021-03-25 |
| Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome (NCT04681417) | Institut Curie | 2021-03-25 |
| To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis (NCT04566666) | Sun Pharmaceutical Industries Limited | 2021-03-25 |
| INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer (NCT04781725) | Ottawa Hospital Research Institute | 2021-03-25 |
| Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma (NCT04523688) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2021-03-25 |
| Cyclosporine on Day Zero as Prophylaxis for Cytokine Release Syndrome (NCT04781803) | Hospital Universitario Dr. Jose E. Gonzalez | 2021-03-25 |
| Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma (NCT04659811) | Nancy Ann Oberheim Bush, MD | 2021-03-25 |
| A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NCT04799158) | Phathom Pharmaceuticals, Inc. | 2021-03-25 |
| Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome (NCT04850378) | University of Aarhus | 2021-03-25 |
| To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray (NCT04817800) | Humanis Saglık Anonim Sirketi | 2021-03-25 |
| Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer (NCT04805736) | The First Affiliated Hospital with Nanjing Medical University | 2021-03-25 |
| ES-481 for Uncontrolled Glioma-Associated Epilepsy and Assessment for Potential Anti-Tumorigenic Effect in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant Tumors (NCT04737174) | ES Therapeutics Australia Pty Ltd | 2021-03-25 |
| Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases (NCT04832204) | Beijing Hospital | 2021-03-25 |
| Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib (NCT04790474) | Tel-Aviv Sourasky Medical Center | 2021-03-25 |
| Evaluation of Cytokine Biomarkers in Melanoma Patients During Immunotherapy (NCT04928365) | Blokhin's Russian Cancer Research Center | 2021-03-25 |
| Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer (NCT04503694) | Jules Bordet Institute | 2021-03-25 |
| DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (NCT04752163) | M.D. Anderson Cancer Center | 2021-03-25 |
| The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture (NCT04702516) | Morten Frost | 2021-03-24 |
| A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19 (NCT04672395) | Clover Biopharmaceuticals AUS Pty | 2021-03-24 |
| Phase II Study of Orelabrutinib Combined With PD-1 Inhibitor in Relapsed/Refractory Primary Central Nervous System Lymphoma (NCT04899427) | Peking Union Medical College Hospital | 2021-03-24 |
| FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms (NCT05312567) | Fervent Pharmaceuticals | 2021-03-24 |
| A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia (NCT04784442) | Otsuka Pharmaceutical Co., Ltd. | 2021-03-24 |
| Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia (NCT04774237) | Visus Therapeutics | 2021-03-24 |
| A Study of JNJ-64304500 in Participants With Alopecia Areata (NCT04740970) | Janssen Research & Development, LLC | 2021-03-24 |
| Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors (NCT04665206) | Vivace Therapeutics, Inc | 2021-03-24 |
| Pilot Study of CC 486 (Oral Azacitidine) Plus BSC as Maintenance After sc Azacitidine in Elderly HR-IPSS-R MDS Patients (NCT04806906) | University of Florence | 2021-03-24 |
| A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS (NCT04681066) | CalciMedica, Inc. | 2021-03-24 |
| Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II (NCT06015854) | University Medical Center Groningen | 2021-03-23 |
| Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells) (NCT04813562) | Jiangsu Province Centers for Disease Control and Prevention | 2021-03-23 |
| 8- Versus 12-week of Sofosbuvir-ravidasvir Treatment of Chronic Hepatitis C (NCT04885855) | Muhammad Radzi Abu Hassan | 2021-03-23 |
| A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors (NCT04761198) | Mereo BioPharma | 2021-03-23 |
| Scopolamine in Bipolar Depression (NCT04211961) | Dr. Brian Hallahan | 2021-03-23 |
| EXPAREL or Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter Placement (NCT05044468) | M.D. Anderson Cancer Center | 2021-03-23 |
| Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease (NCT04824911) | Chang Gung Memorial Hospital | 2021-03-23 |
| JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors (NCT04720976) | Allist Pharmaceuticals, Inc. | 2021-03-23 |
| Emicizumab in Acquired Hemophilia A (NCT04188639) | GWT-TUD GmbH | 2021-03-23 |
| EXtended CriteriA Treatment for LIver Metastases and Heavy Tumour BURden (NCT04840186) | Oslo University Hospital | 2021-03-23 |
| A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM) (NCT04816890) | Adocia | 2021-03-23 |
| Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trial (NCT04307329) | The Netherlands Cancer Institute | 2021-03-23 |
| An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene. (NCT04855045) | ProQR Therapeutics | 2021-03-23 |
| Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD (NCT05066334) | Fondazione Policlinico Universitario Campus Bio-Medico | 2021-03-22 |
| A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis) (NCT04817007) | Bristol-Myers Squibb | 2021-03-22 |
| Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer (NCT04499924) | Seagen Inc. | 2021-03-22 |
| A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma (NCT04829383) | Howard S Hochster | 2021-03-22 |
| Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia (NCT04605484) | AlloVir | 2021-03-22 |
| Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma (NCT04649476) | Hospital of Stomatology, Wuhan University | 2021-03-22 |
| Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers (NCT04803708) | Technophage, SA | 2021-03-22 |
| Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone (NCT04049331) | Seattle Institute for Biomedical and Clinical Research | 2021-03-22 |
| OTO-313 in Subjects With Unilateral Subjective Tinnitus (NCT04829214) | Otonomy, Inc. | 2021-03-22 |
| Metformin in Alzheimer's Dementia Prevention (NCT04098666) | Columbia University | 2021-03-22 |
| A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) (NCT04677179) | Nektar Therapeutics | 2021-03-22 |
| Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging (NCT04815603) | BioAge Labs, Inc. | 2021-03-22 |
| A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail (NCT04188574) | Blueberry Therapeutics | 2021-03-22 |
| A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites (NCT04835480) | Healthgen Biotechnology Corp. | 2021-03-22 |
| A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome. (NCT04830644) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2021-03-22 |
| A Trial for Relapsed Multiple Myeloma Patients (Isatuximab-dexamethasone) (NCT04965155) | EMN Trial Office S.r.l. Impresa Sociale | 2021-03-21 |
| Roflumilast as add-on Therapy in Early Cases of ARDS (NCT04744090) | Cairo University | 2021-03-21 |
| Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients (NCT05097781) | Ruijin Hospital | 2021-03-21 |
| the Effect of Ozone Oil on the Postoperative Sequalae After Surgical Removal of Third Molar (NCT05544539) | University of Baghdad | 2021-03-21 |
| Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial (NCT05053802) | Shanghai Pulmonary Hospital, Shanghai, China | 2021-03-21 |
| Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia (NCT04902781) | Applied Therapeutics, Inc. | 2021-03-20 |
| Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand (NCT04764422) | Mahidol University | 2021-03-20 |
| Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia (NCT04683237) | Xiaojun Chen | 2021-03-20 |
| Phase Ⅱ Trial of Camrelizumab in Patients Without Distant Metastasis Nasopharyngeal Carcinoma (NCT04782765) | Tianjin Medical University Cancer Institute and Hospital | 2021-03-20 |
| A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19 (NCT04780685) | Stemedica Cell Technologies, Inc. | 2021-03-20 |
| Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS) (NCT04621188) | Intergroupe Francophone de Cancerologie Thoracique | 2021-03-19 |
| A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors (NCT04731467) | Famewave Ltd. | 2021-03-19 |
| The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19 (NCT04891302) | Bukwang Pharmaceutical | 2021-03-19 |
| Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC) (NCT04644237) | Daiichi Sankyo | 2021-03-19 |
| Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients (NCT04809181) | First Affiliated Hospital of Zhejiang University | 2021-03-19 |
| Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke (NCT04760717) | Yale University | 2021-03-19 |
| INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders (NCT04455841) | Incyte Corporation | 2021-03-19 |
| 68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer (NCT04483414) | Dana Mathews | 2021-03-19 |
| Evaluation of the Photobiomodulation Using LED Lamp for Curative Treatment of Radio-induced Mucositis. (NCT04251949) | Centre Oscar Lambret | 2021-03-19 |
| Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST) (NCT04739202) | Hospices Civils de Lyon | 2021-03-19 |
| Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT04387227) | University of Washington | 2021-03-18 |
| A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors (NCT04799054) | Ascendis Pharma Oncology Division A/S | 2021-03-18 |
| Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis (NCT04356664) | Hopital Foch | 2021-03-18 |
| Sphenopalatine Ganglion Block for Headache After Concussion (NCT04650282) | University of Michigan | 2021-03-18 |
| Effect of Magnesium Supplementation in Selective Serotonin Reuptake Inhibitors Treated Major Depressive Disorder Patients (NCT04880460) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2021-03-18 |
| Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma (NCT04784247) | Memorial Sloan Kettering Cancer Center | 2021-03-18 |